• Linkedin
  • Twitter
  • Youtube
  • Facebook
  • Instagram
HCS Pharma
  • Company
    • About us
    • Team
    • Scientific Advisory Board
    • Advisory Board
    • Investors Relations
    • R&D programs and partnerships
      • BioPharMEMS
      • MIMLIVEROnChip
      • Nanostem
      • NEUROCELL3D
      • ONCO3D
      • RHU CHOPIN
      • ScaLABle-MEAT
      • VisuAI
    • Pressroom
      • Press releases
      • Photos for the press
      • HCS Pharma in press
    • Customer testimonials
    • Labels, prizes and distinctions
    • Partners and Memberships
    • Careers
    • Privacy Policy
  • BIOMIMESYS®
    • What is BIOMIMESYS® hydroscaffold?
    • BIOMIMESYS® Brain
    • BIOMIMESYS® Liver
    • BIOMIMESYS® Adipose tissue
    • BIOMIMESYS® Oncology
    • BIOMIMESYS® Custom
    • How to buy BIOMIMESYS®?
  • Support
    • BIOMIMESYS® Custom
    • Dermocosmetology
      • Anti-Aging
      • Anti-Oxidant
      • Anti-Redness
      • Wound Healing
      • Skin Pigmentation
      • Anti-Pollution
      • Skin Microbiota
      • Cosmetics custom developments
    • Pharmacology
      • Parkinson
      • Alzheimer
      • Migration
      • Cell cycle arrest
  • Ressources
    • Publications – Scientific articles
    • Application Notes
    • Conferences & Webinars
    • News
    • Posters
    • Brochures
    • BIOMIMESYS® tutorials
    • Customer testimonials
    • Certificate of Analyse
    • TDS&MSDS
    • Protocols
    • Frequently Asked Questions
  • Contacts
    • How to contact us?
    • How to buy BIOMIMESYS®?
    • Subscribe to our Newsletter

ELRIG

News

Summary ELRIG UK in London last week

Last week we attended ELRIG UK Drug Discovery meeting in ExCeL London, and it was a great pleasure for us to present our poster about neurotoxicity testing using HCS there. Many interesting posters were displayed in the vendor area (see below), allowing exciting scientific discussions between the sessions! We enjoyed Read more…

By Elodie Vandenhaute, 4 yearsOctober 16, 2018 ago
News

HCS Pharma @ Drug Discovery 2018

Our study director Elodie will attend Drug Discovery 2018 – THE ELRIG‘s flagship conference – which will take place in London next week! We are looking forward to presenting our poster about neurotoxicity testing. Don’t hesitate to visit Elodie there, she will answer to your questions about our results, and/or our different services! Read more…

By Elodie Vandenhaute, 4 yearsOctober 4, 2018 ago
News

Our last experience in ELRIG Fr and EUROoC meetings!

We had the pleasure to attend ELRIG Fr meeting in Bischoffsheim (near Strasbourg)  on the 23-24th of May. There we enjoyed meeting our partners Molecular Devices and Integra biosciences, and seeing great presentations about the last trends in automation. Our collaborator Karim Si-Tayeb presented his amazing results regarding the differentiation Read more…

By Elodie Vandenhaute, 5 yearsJune 12, 2018 ago
News

Thanks ELRIGfr, Monaco event was great and it’s always a pleasure to talk about augmented reality !

Last week, I was at ELRIGfr meeting in Monaco, as president of RA’pro (Association for the Promotion of Augmented Reality), to chair an augmented reality workshop with famous societies as Molecular Devices, Sopra Steria, agence dad and Microtechnix.  Many other things were of course interesting and, even if I’m not Read more…

By Grégory MAUBON, 5 yearsDecember 11, 2017 ago
News

Ready to ELRIGfr Monaco with a special workshop on augmented reality ?

Discover how immersive technologies could help you in laboratories

By Nathalie MAUBON, 5 yearsNovember 21, 2017 ago
News

Great symposium at Drug Discovery 2016 !

13th and 14th October 2016, drug discovery 2016 was held in Liverpool, UK. We really enjoyed our venue at the 10th anniversary of ELRIG drug discovery symposium.

By Pierre Jean Ferron, 6 yearsOctober 27, 2016 ago
News

Feed-back of ELRIGfr Rennes 2016

140 people attented the previous ELRIGfr event in Rennes, co-organized by ELRIGfr and HCS Pharma

By Nathalie MAUBON, 7 yearsMay 29, 2016 ago
News

Next ELRIGfr event takes place in Rennes, 3 & 4 may 2016

We are very proud to contribuate to organize next ELRIGfr in Rennes. The central topic will be “Lab Automation, Formulation & Phenotypic screening”

By Grégory MAUBON, 7 yearsFebruary 9, 2016 ago
News

Meet us at Drug Discovery 2015 in Telford the 2nd & 3rd of September

We will be present in the “innovation zone” during the Drug discovery 2015 in Telford the 2nd and 3rd of September in Telford.

By Nathalie MAUBON, 8 yearsJuly 20, 2015 ago
Posters

Poster – Development of co-culture Parkinson’s disease model using High Content Screening technology

Download our poster

By Grégory MAUBON, 8 yearsMarch 27, 2015 ago
News

My impression of ELRIG Drug Discovery 2014

I was really impressed by the size and quality of the Drug Discovery 2014 organised by ELRIG in Manchester. More than 1,500 scientists participated in this meeting and nearly 100 exhibitors were present. Phentoypic screening and high content screening were prominent in this conference and we could hear researchers from Roche, Astrazeneca, Read more…

By Nathalie MAUBON, 8 yearsSeptember 12, 2014 ago
News

ELRIG congress: Drug discovery 2014

Come and joins us to the congress organised by ELRIG: drug discovery 2014. A specific new session on phenotypic discovery and cellular imaging will be implemented in the 2014 programm. I you want to learn more about this congress and to register, follow this link! We are pleased to see you Read more…

By Nathalie MAUBON, 9 yearsJune 11, 2014 ago
Clic to get more information

BIOMIMESYS®

Contacts
Contact us with this form!
Or
+33 769 999 137

Newsletter

Recent Posts
  • New 3D in vitro model of dysbiosis-induced colon cancer thanks to France Relance Plan
  • Retrospective HCS Pharma 2022
  • Animal tests no longer necessary before drug clinical trials? Let’s make it in 3D in preclinical studies… and with the extracellular matrix!
  • Tokyo Future Style Taiwan presented our BIOMIMESYS® products during Taiwan Healthcare Expo 2022
  • We were in Cosmet’Agora last week !
We talk about …
3D 3D cell culture 3D culture BIOMIMESYS BIOMIMESYS Brain blood brain barrier brain cancer cell congress cosmetology dermocosmetology drug ECM ELRIG event extracellular matrix genotoxicity HCS hcs pharma High content screening hyaluronic acid hydroscaffold imaging innovation in vitro in vitro models liver meeting Microbiota microscopy Molecular Devices NEUROCELL3D neurons neurotoxicity oncology organoids Parkinson phenotypic screening picture presentation screening skin toxicology webinar
  • Company
  • BIOMIMESYS®
  • Support
  • Ressources
  • Contacts
HCS Pharma (c) 2021 | Hestia | Powered by WordPress
 

Loading Comments...